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Expanded Abstract 
Citation 
Safdar N, Maki DG: Risk of catheter-related bloodstream 
infection with peripherally inserted central venous catheters 
used in hospitalized patients. Chest 2005, 128:489-495 [1]. 
Background 
Peripherally inserted central venous catheters (PICCs)
 are 
widely used for intermediate and long-term access, 
especially in the inpatient setting,
  where they are 
increasingly supplanting conventional central
  venous 
catheters (CVCs). Data on the risk of PICC-related
 
bloodstream infection (BSI) hospitalized
 patients are limited. 
Methods 
Objective:  To determine the risk of PICC-related BSI
  in 
hospitalized patients. 
Design:  Prospective cohort study using data from two 
randomized
  trials assessing the efficacy of chlorhexidine-
impregnated sponge
  dressing and chlorhexidine for 
cutaneous antisepsis. 
Subjects: PICCs inserted into the antecubital vein in two 
randomized
  trials conducted from 1998 to 2000 were 
prospectively studied;
 most patients were in an ICU. 
Measurements:  PICC-related BSI was confirmed
  in each 
case by demonstrating concordance between isolates 
colonizing
 the PICC at the time of removal and from blood 
cultures, using restriction-fragment
 DNA subtyping. 
Results: Overall, 115 patients had 251 PICCs placed. 
Mean duration
 of catheterization was 11.3 days (total, 2,832 
PICC-days); 42%
 of the patients were in an ICU at some 
point, 62% had urinary
  catheters, and 49% received 
mechanical ventilation. Six
  PICC-related BSIs were 
identified (2.4%), four with coagulase-negative
 
staphylococcus, one with Staphylococcus aureus, and one 
with
  Klebsiella pneumoniae, for a rate of 2.1 per 1,000 
catheter-days. 
Conclusion 
This prospective study shows that PICCs used in high-risk 
hospitalized patients are associated with a rate of catheter-
related BSI similar to conventional CVCs placed in the 
internal jugular or subclavian veins (2 to 5 per 1,000 
catheter-days), much higher than with PICCs used 
exclusively in the outpatient setting (approximately 0.4 per 
1,000 catheter-days), and higher than with cuffed and 
tunneled Hickman-like CVCs (approximately 1 per 1,000 
catheter-days). A randomized trial of PICCs and 
conventional CVCs in hospitalized patients requiring central 
access is needed. Our data raise the question of whether 
the growing trend in many hospital hematology and 
oncology services to switch from use of cuffed and tunneled 
CVCs to PICCs is justified, particularly since PICCs are 
more vulnerable to thrombosis and dislodgment, and are 
less useful for drawing blood specimens. Moreover, PICCs 
are not advisable in patients with renal failure and 
impending need for dialysis, in whom preservation of upper-
extremity veins is needed for fistula or graft implantation. 
Commentary 
The use of peripherally inserted central catheters (PICCs) 
for intermediate and long-term venous access has 
increased steadily over the past decade. Many intensive 
care unit (ICU) patients are receiving PICCs even before 
they are ready to leave the ICU. Most prior studies 
examining PICC-related blood stream infection (PR-BSI) 
were retrospective, and nearly all were done in outpatient 
settings. Based on these studies, PICCs are widely believed 
to be less prone to infection than conventional CVCs. 
However, data regarding the risk of infection for PICCs 
placed in an ICU setting are relatively scarce. In the current 
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study, Maki and colleagues [1] investigated the risk of PR-
BSI in hospitalized patients, 42% of which were in the ICU. 
They did so by examining BSI rates in patients with newly 
inserted PICCs, using data from two randomized
 trials that 
assessed different skin preparation and care techniques 
[2,3]. While not the primary point of these trials, the methods 
used for identifying BSIs and determining if a PICC was to 
blame were robust. The authors found an incidence of PR-
BSI of 2.1 per 1000 catheter-days. This rate of infection was 
substantially higher than has been seen in outpatients and 
is equivalent to the rate reported for conventional CVCs. 
Furthermore, the authors found a similarly high incidence of 
inpatient PR-BSI when pooling results of other, less 
methodologically sound, studies. 
A few limitations deserve consideration. The two trials from 
which this study derived its data were only published in 
abstract form. Thus, we do not know many details of the 
parent trials that might help in our interpretation of the data, 
such as how long subjects were in the hospital or ICU, what 
antibiotics they received prior to PICC insertion, or how long 
antibiotics were given. Some patients in the parent trials 
received conventional CVCs. Rates of CVC-related BSI for 
these subjects were not reported and instead the authors 
provide reported rates from the literature to put the 
observed PR-BSI rates in perspective. 
PICC-related risks are not limited to BSI, but also include 
insertion-related complications, phlebitis, thrombosis, and 
premature dislodgement. Physicians must carefully weigh 
these risks, as well as those of alternative devices, such as 
CVCs, when choosing the best access for their patients. 
Consideration must also be given to the “appropriate” time 
in the course of illness for PICC insertion and how long a 
PICC can be left in place without significantly increasing the 
risk of infection. 
Recommendation 
We concur with the authors that a better prospective study 
of PR-BSI in high-risk hospitalized patients is needed. Such 
a trial should compare PICCs and conventional CVCs. 
Based on the results of this and other studies, clinicians 
may want to more strongly consider a PICC as a potential 
source of infection. 
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